Skip to main content
Clinical Trials/NCT04449601
NCT04449601
Completed
Not Applicable

Comparison of Maternal Neonatal Outcomes of Normotensive and Hypertensive Placental Abruptions: A Novel Approach

Hatice Akkaya0 sites115 target enrollmentJanuary 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Abruptio Placentae; Affecting Fetus or Newborn
Sponsor
Hatice Akkaya
Enrollment
115
Primary Endpoint
blood pressure measurement
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Placental abruption is a significant cause of both maternal morbidity and neonatal morbidity and mortality. Most abruptions accept to be related to a chronic placental disease process. Therefore, it is very important to understand these processes. To analyze maternal and neonatal effects of placental abruption(PA) through a novel classification in the presence of hypertension. Initial hemoglobin parameters were also compared to predict pregnancy outcomes in addition to hypertension.

Detailed Description

Objective: We aimed to classify placental abruption according to hypertension status. Methods: This retrospective cohort designed study was conducted on 115 pregnant women with placental abruption. The main parameters scanned and recorded from the hospital database and patient medical files. Two groups were classified regarding of presence or absence of hypertension (53 hypertensive, 62 normotensive). Maternal demographical and clinical characteristics (abdominal pain, vaginal bleeding) were recorded. APGAR scores below 5 at 1 and 5 min., fetal or neonatal death, admission and length of stay in Neonatal Intensive Care Unit(NICU) were also investigated and compared between the groups.

Registry
clinicaltrials.gov
Start Date
January 1, 2016
End Date
November 30, 2017
Last Updated
5 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Hatice Akkaya
Responsible Party
Sponsor Investigator
Principal Investigator

Hatice Akkaya

Associate Professor

Kayseri Education and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • spontaneous,
  • singleton pregnancies
  • above 25 weeks of gestations with positive fetal cardiac activity

Exclusion Criteria

  • multiple gestations,
  • presence of fetal or maternal infection,
  • chronic inflammatory diseases or connective tissue disorders
  • history of myocardial infarction,
  • thrombosis
  • history of steroid drug usage.

Outcomes

Primary Outcomes

blood pressure measurement

Time Frame: 2 minute

mm Hg

Secondary Outcomes

  • maternal and newborn length, weight(5 minute)
  • hemogram parameters WBC(white blood cell) ,PLT(Platelet), MPV(mean platelet volume), HGB(hemoglobin), Neutrophil lymphocyte ratio..)(first 1 hour)
  • APGAR score(5 minute)

Similar Trials